Pityriasis versicolor;Pitiríase versicolor

Anais Brasileiros de Dermatologia

Volumn 77, Issue 5, 2002, Pages 611-618

  Rodrigues de Oliveira, Josenildo ^a   Tom Mazocco, Viviane ^a   Steiner, Denise ^b  

^a FACULDADE DE MEDICINA DE JUNDIAÍ   (Brazil)

^b NONE   (Brazil)

Author keywords

Fungi; Malassezia; Pityriasis

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE; SELENIUM SULFIDE; TERBINAFINE;

ABDOMINAL PAIN; CLIMATE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DRUG CHOICE; EPIDEMIOLOGICAL DATA; FUNGUS IDENTIFICATION; HEADACHE; HISTOPATHOLOGY; HUMAN; LIVER TOXICITY; MALASSEZIA FURFUR; NAUSEA; PATHOGENESIS; PREVALENCE; RECURRENT DISEASE; REVIEW; SKIN FLORA; SKIN PIGMENTATION; TINEA VERSICOLOR; TROPICS;

EID: 0036760427     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0365-05962002000500012     Document Type: Review

References (50)

1. Michalowski R, Rodziewicz H. Pityriasis versicolor in children. Br. J. Dermatol. 1963; 75: 397-400.
2. Adamski Z. Studies of a role played by lipophilic yeasts Malassezia furfur (Pityrosporum ovale, Pityrosporum orbiculare) in different dermatoses. Postepy Dermatol (Poznan) 1995; 12: 349-454.
3. Zaitz C - Dermatoses associadas às leveduras do gênero Malassezia. An Bras Dermatol 2000; 75 (2): 129-142.
4. Sunenshine PJ, Schwartz RA, Janniger CK. Review. Tinea versicolor. Int J Dermatol 1998; 37: 648-655.
5. Bailon H. Traite de Botanique Medicale Cryptogamique. Paris: Octave Doin, 1889: 234.
6. Robin C. Historie Naturelle des Vegeaux Parasites. London: Balliere, 1853: 438.
7. Gordon MA. The lipophilic mycoflora of the skin. Mycologica 1951; 43: 524-534.
8. Castellani A, Chalmers AJ. Manual of Tropical Medicine, 2nd Edn. New York: Wm. Wood & Co., 1913: 936-837.
9. Gordon MA. Lipophilic yeastlike organisms associated with tinea versicolor. J Invest Dermatol 1951; 17: 267-272.
10. Savin R. Diagnosis and treatment of tinea versicolor. J Fam Pract 1996; 43: 127-132.
11. Nowiscki R, Sadowska E. Mycotic infections in the Gdansk area. Przegl Dermatol 1993; 80: 245-250.
12. Akpata LE, Gugnani HC, Utsalo SJ. Pityriasis versicolor in school children in Cross River State of Nigeria. Mycoses 1990; 33: 549-551.
13. Bergbrant IM, Faergemann J. Variations of Pityrosporum orbiculare in middle-aged and elderly individuals. Acta Derm Venereol 1988; 68: 537-540.
14. Bergbrant IM, Brobeg A. Pityrosporum ovale culture from the forehead of healthy children. Acta Derm Venereol 1994; 74: 260-261.
15. Terragni L, Lasagni A, Oriani A, Gelmetti C. Pityriasis versicolor in the pediatric age. Pediatr Dermatol 1991; 8: 9-12.
16. Miskeen AK, Kelkar SS, Shroff HJ. Pityriasis versicolor in children. Indian J Dermatol Venereol Leprol 1984; 50: 144-146.
17. Roberts SOB. Pityrosporum orbiculare: Incidence and distribution on clinically normal skin. Br Dermatol 1969; 81: 264-269.
18. Faergemann J. Lipophilic yeasts in skin disease. Semin Dermatol 1985; 4: 173-184.
19. Faergemann J, Aly R, Maibach HI. Growth and filament production of Pityrosporum orbiculare and P. ovale on human stratum comeum in vitro. Acta Derm Venereol 1983; 63: 388-392.
20. Salkin IF, Gordon MA. Polymorphism of Malassezia furfur. Can J Microbiol 1977; 23: 471-475.
21. Faergemann J, Tjernlund U, Scheynius A, Sverker B. Antigenic similarities and differences in genus Pityrosporum. J Invest Dermatol 1982; 78: 28-31.
22. Cunningham AC, Leeming JP, Ingham E, Gowland G. Differentiation of three serovars of Malassezia furfur. J Appl Bacteriol 1990; 68: 439-446.
23. Ashbee HR, Ingham E, Holland KT, Cunliffe WJ. The carriage of Malassezia furfur serovars A, B, and C in patients with pityriasis versicolor, seborrhoeic dermatitis and controls. Br J Dermatol 1993; 129: 533-540.
24. Ashbee HR, Ingham E, Holland KT, et al. The role of Malassezia furfur serovars A, B, and C in Pityriasis versicolor and seborrhoeic dermatitis. Br J Dermatol 1991; 125: 495.
25. Schmidt A. Malassezia furfur: A fungus belonging to the physiological skin flora and its relevance in skin disorders. Cutis 1997; 59: 21-24.
26. Leeming JP, Notman FH, Holland KT. The distribution and ecology of Malassezia furfur and cutaneous bacteria on human skin. J Appl Bacteriol 1989; 67: 47-52.
27. Breathnach AS, Nazzaro Porro M, Martin B. Ultrastructure of skin in pityriasis versicolor. Giomale Italiano di Dermatologia-Minerva Dermatologica 1975; 110: 457-469.
28. Scheynius A, Faergemann J, Forsum U, Sjoberg O. Phenotypic characterization in situ of inflammatory cells in pityriasis (tinea) versicolor. Acta Derm Venereol 1984; 64: 473-479.
29. King RD, Cunico RL, Maibach HI, et al. The effect of occlusion on carbon dioxide emission from human skin. Acta Derm Venereol 1978; 58: 135-138.
30. Faergemann J, Bernander S. Tinea versicolor and Pityrosporum orbiculare. A mycological investigation. Sabouraudia 1979; 17: 171-179.
31. Congly H. Pityriasis versicolor in a 3-month-old boy. Can Med Assoc J 1984; 130: 844-845.
32. Roberts SOB. Pityriasis versicolor: A clinical and mycological investigation. Br J Dermatol 1969; 81: 315-326.
33. Burke RC. Tinea versicolor: Susceptibility factors and experimental infections in human beings. J Invest Dermatol 1961; 36: 389-402.
34. Elewski BE, Hazen PG. The superficial mycoses and the dermatophytes. J Am Dermatol 1989; 21: 655-673.
35. Heng MCY, Henderson CL, Barker DC, Haberfelde G. Correlation of Pityrosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990; 23: 82-86.
36. Crozier WJ, Wise KA. Onychomycosis due to Pityrosporum. Australas J Dermatol 1993; 34: 109-112.
37. Sohnle PG, Collins-Lech C. Cell-mediated immunity to Pityrosporum orbiculare in tinea versicolor. J Clin Invest 1978; 62: 45-53.
38. Hashim FA, Elhassan AM. Tinea versicolor and visceral leishmaniasis. Int J Dermatol 1994; 33: 258-259.
39. De Luca C, Picardo M, Breathnach A, et al. Lipoperoxidase activity of Pityrosporum: Characterization of by-products and possible role in pityriasis versicolor. Exper Dermatol 1996; 5: 49-56.
40. Nazzaro-Porro M. Identification of tyrosinase inhibitors in cultures of Pityrosporum. J Invest Dermatol 1978; 71: 205-208.
41. Soyer HP, Cerroni L. The significance of histopathology in the diagnosis of dermatomycoses. Acta Dermatovenerologica Alpina Pannonica et Adriatica 1992; 1: 84-87.
42. Galadari I, El-Komy M, Mousa A, et al. Tinea versicolor: Histologic and ultrastructural investigation of pigmentary changes. Int J Dermatol 1992; 31: 253-256.
43. Schwartz RA, Fox MD. Office Dermatology. Kansas City, Missouri: American Academy of family Physicians Publications, 1992.
44. Terragni L, Lasagni A, Oriani A. Pityriasis versicolor of the face. Mycoses 1991; 34: 345-347.
45. Daneshvar SA, Hashimoto K. An unusual presentation of tinea versicolor in an immunosuppressed patient. J Am Acad Dermatol 1987; 17: 304-305.
46. Conill C, Azón-Masoliver A, Verger E, et al. Pityriasis versicolor confined to the radiation therapy field. Acta Oncol 1990; 29: 949-950.
47. Aly R, Berger T. Common superficial fungal infections in patients with AIDS. Clin Infect Dis 1996; 22: S128-S132.
48. Elmets CA. Management of common superficial fungal infections in patients with AIDS. J Am Acad Dermatol 1994; 31: S60-S63.
49. Karaoui R, Bou-Resli M, Al-Zaid NS, Mousa A. Tinea versicolor: Ultrastructural studies on hypopigmented and hyperpigmented skin. Dermatologica 1981; 132: 69-85.
50. Savin R. Diagnosis and treatment of tinea versicolor. J Fam Pract 1996; 43: 127-132.